4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / An Engineering-Based Balance Assessment and Training Platform (BATP)

An Engineering-Based Balance Assessment and Training Platform (BATP)

Study Description
Brief Summary:
This is a proposal to develop a Balanced Reach Training Protocol (BRTP) to evaluate and train dynamic standing balance. The BRTP is based upon the Balanced Reach Test (BRT) that the investigators previously developed and validated. In the BRT subjects stand and point to a target disk moving unpredictably across a large projection screen in front of them without stepping. Body movements undertaken to track the disk are integral to many daily activities and represent an important class of "expected" balance disturbances that can precipitate falls. The BRTP employs engineering and psychophysical methods, and exploits advances in real time computing in a novel and innovative way to more effectively evaluate and train balance function. The BRTP presents a challenging reaching/tracking task that subjects perform at their limit of balance. The BRTP is an objective, quantitative test that can evaluate balance function without floor or ceiling effects, and train balance across the spectrum of aging, disease, and injury.

Condition or disease Intervention/treatment Phase
Balance Deficits Stroke Diagnostic Test: Balanced Reach Assessment and Training Protocol Not Applicable

Show Show detailed description
Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: Once the BATP is developed 20 stroke subjects will be recruited and the BATP's Assessment Module will be administered in order to verify its operation. After this is complete 10 stroke subjects will be randomly selected from this group and will undergo three one-hour training sessions over the course of one week to assess the operation of the BATP's Training Module.
Masking: None (Open Label)
Primary Purpose: Other
Official Title: An Engineering-Based Balance Assessment and Training Platform
Estimated Study Start Date : July 30, 2021
Estimated Primary Completion Date : June 30, 2022
Estimated Study Completion Date : June 30, 2022
Arms and Interventions
Arm Intervention/treatment
STR
Older people who have suffered a stroke
Diagnostic Test: Balanced Reach Assessment and Training Protocol
Three one-hour training sessions for one week in the Balanced Reach Training Protocol

Outcome Measures
Primary Outcome Measures :
  1. Root Mean Squared Deviation between Center of Mass and Center of Base of Support (RMSD) [ Time Frame: Assess change between base line (just prior to training) and last 90 seconds of last training session at end of 1 week ]
    Measure of Balance Capability. Root Mean Squared Deviation (RMSD) records the root mean squared distance between the ground plane projection of whole-body Center of Mass and the center of the Base of Support during performance of the balanced reach task, in centimeters. It ranges from zero to the distance from the center of the Base of Support to the boundary of the Base of Support. Larger deviations indicate better performance than smaller deviations.


Secondary Outcome Measures :
  1. Multi-Directional Reach Test [ Time Frame: Assess change between base line (just prior to training) and within 24 hours of the end of training (1 week) ]
    Measures ability to lean and reach. Multi-Directional Reach Test records the distance in centimeters that one can reach in the forward, backward, rightward, and leftward directions; by bending at the waist and reaching with arm extended in each associated direction. Larger distances indicate better performance than smaller distances.

  2. Falls Efficacy Scale [ Time Frame: Assess change between base line (just prior to training) and within 24 hours of the end of training (1 week) ]
    Assesses fear of falling. The Falls Efficacy Scale is a self-report questionnaire providing information on level of concern about falls for a range of activities of daily living. The questionnaire contains 16 items scored on a four-point scale (1 = not at all concerned to 4 = very concerned). The overall score is the sum of the 16 scores that are provided and ranges from 1to 64. Overall scores between 16-19 indicate low fear of falling; 20-27 indicates moderate fear of falling; and 28-64 indicates high fear of falling. Lower scores are better than higher scores.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   65 Years to 86 Years   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ischemic stroke with residual hemiparetic gait
  • Adequate language and neurocognitive function to participate in testing and training
  • Able to give adequate informed consent
  • Completion of all regular physical therapy
  • Capable of performing the BATP Assessment and Training tasks without assistive devices or handholds
  • Able to tolerate the use of AVR eyewear for ~10 minutes

Exclusion Criteria:

Clinical history of:

  • unstable angina
  • recent myocardial infarction (< 3 month) or hemodynamically significant congestive heart failure (NYHA II) or valvular dysfunction
  • peripheral arterial occlusive disease with claudication
  • major orthopedic, chronic pain, or conditions restricting exercise
  • pulmonary or renal failure
  • Body Mass Index (BMI) >40
  • active vertigo
  • symptomatic orthostatic hypotension
  • poorly controlled hypertension (>190/105) on at least two separate occasions
  • poorly controlled type 1 or 2 diabetes (HbA1c >10)
  • recent hospitalization for severe disease or surgery (<3 month)
  • excessive daily alcohol consumption (>3 oz. liquor; >12 oz. wine; or >36 oz. beer) or illicit drug abuse
  • untreated major clinical depression or dementia
  • major neurological disease other than stroke, such as Parkinson's disease, multiple sclerosis, etc.
  • any condition (e.g., extreme obesity or frailty) that would preclude safe completion of the BATP
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Joseph E Barton, MD PhD (202) 337-5921 jbarton@som.umaryland.edu

Locations
Layout table for location information
United States, Maryland
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, United States, 21201
Contact: Joseph E Barton, MD PhD    202-337-5921    jbarton@som.umaryland.edu   
Principal Investigator: Joseph E. Barton, MD PhD         
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Layout table for investigator information
Principal Investigator: Joseph E. Barton, MD PhD Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Tracking Information
First Submitted Date  ICMJE June 14, 2019
First Posted Date  ICMJE June 21, 2019
Last Update Posted Date June 7, 2021
Estimated Study Start Date  ICMJE July 30, 2021
Estimated Primary Completion Date June 30, 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: June 20, 2019)
Root Mean Squared Deviation between Center of Mass and Center of Base of Support (RMSD) [ Time Frame: Assess change between base line (just prior to training) and last 90 seconds of last training session at end of 1 week ]
Measure of Balance Capability. Root Mean Squared Deviation (RMSD) records the root mean squared distance between the ground plane projection of whole-body Center of Mass and the center of the Base of Support during performance of the balanced reach task, in centimeters. It ranges from zero to the distance from the center of the Base of Support to the boundary of the Base of Support. Larger deviations indicate better performance than smaller deviations.
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: June 20, 2019)
  • Multi-Directional Reach Test [ Time Frame: Assess change between base line (just prior to training) and within 24 hours of the end of training (1 week) ]
    Measures ability to lean and reach. Multi-Directional Reach Test records the distance in centimeters that one can reach in the forward, backward, rightward, and leftward directions; by bending at the waist and reaching with arm extended in each associated direction. Larger distances indicate better performance than smaller distances.
  • Falls Efficacy Scale [ Time Frame: Assess change between base line (just prior to training) and within 24 hours of the end of training (1 week) ]
    Assesses fear of falling. The Falls Efficacy Scale is a self-report questionnaire providing information on level of concern about falls for a range of activities of daily living. The questionnaire contains 16 items scored on a four-point scale (1 = not at all concerned to 4 = very concerned). The overall score is the sum of the 16 scores that are provided and ranges from 1to 64. Overall scores between 16-19 indicate low fear of falling; 20-27 indicates moderate fear of falling; and 28-64 indicates high fear of falling. Lower scores are better than higher scores.
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE An Engineering-Based Balance Assessment and Training Platform
Official Title  ICMJE An Engineering-Based Balance Assessment and Training Platform
Brief Summary This is a proposal to develop a Balanced Reach Training Protocol (BRTP) to evaluate and train dynamic standing balance. The BRTP is based upon the Balanced Reach Test (BRT) that the investigators previously developed and validated. In the BRT subjects stand and point to a target disk moving unpredictably across a large projection screen in front of them without stepping. Body movements undertaken to track the disk are integral to many daily activities and represent an important class of "expected" balance disturbances that can precipitate falls. The BRTP employs engineering and psychophysical methods, and exploits advances in real time computing in a novel and innovative way to more effectively evaluate and train balance function. The BRTP presents a challenging reaching/tracking task that subjects perform at their limit of balance. The BRTP is an objective, quantitative test that can evaluate balance function without floor or ceiling effects, and train balance across the spectrum of aging, disease, and injury.
Detailed Description

This study comprises two Specific Aims: SA-1) Development of a Balance Assessment and Training Platform (BATP) based upon the existing BRT; and SA-2) Evaluation of the BATP Assessment Module's test-retest reliability and the Training Module's motor learning effect.

Methods related to Specific Aim 1 SA-1.1: Develop a BATP based on the BRT that incorporates real-time computing and an Adaptive Staircase Algorithm to establish subjects' Limit of Balance. Modify the BRT's experimental control algorithm and hardware setup such that data from our extant measurement systems are continuously streamed to a Real Time Computing Workstation and read by the experimental control algorithm, enabling it to monitor foot movement and compute key performance measures on an ongoing basis. These measures will include Root Mean Square tracking Error (RMSE) and Root Mean Squared Deviation (RMSD) between the ground plane projection of Center of Mass (CoM) and the center of the Base of Support (BoS). Incorporate an Adaptive Staircase Algorithm into the real time experimental control algorithm to establish the target positions corresponding to Limit of Balance, based on foot movement (i.e., stepping).

SA-1.2: Replace the projection screen with Virtual Reality eyewear. The experimental control algorithm will be further modified to display a virtual sphere in the virtual reality eyewear. The virtual reality eyewear will provide a direct view of the actual physical environment but also show the sphere following the trajectory specified by the Adaptive Staircase Algorithm, or the assessment or training modules. When the subject's tracking fingertip contacts the center of the target sphere it will provide visual feedback by changing color.

SA-1.3: Develop the BATP's Assessment and Training modules. The Assessment Module consists of measuring the subject's Limit of Balance, computing the manifold bounding target motion, and the target's motion within the manifold; as just described. The harnessed subject then tracks the disk for 90 sec. After a 2 1/2 minute rest the process is repeated a second time. Tracking and resting durations can be varied to optimize measurement quality and accommodate individual subject needs and capabilities.

The Training Module operates in a loop that presents an operator-specified number of training bouts. One training bout consists of measuring Limit of Balance, computing the manifold and target motion, presenting the tracking target for five minutes, and pausing for a 2 1/2 minute rest period before signaling the operator to begin the next bout. Tracking and resting durations can be varied to optimize training efficacy and accommodate individual subject needs and capabilities. For this proposal a training session will consist of five bouts and last approximately 60 minutes. As in the Assessment Module, subjects will be harnessed while performing the tracking task to guard against falling.

The Assessment and Training modules both collect the same data (All data will be saved for offline, post-test analyses: a) The values of r and corresponding to each Limit of Balance, and Limit of Balance; b) The motion (position vs. time) of the target sphere; c) The motion of each of 13 body segments, as well as the tip of the tracking finger [these data will be used to compute tracking error (RMSE), balance stability (RMSD), and to inform the Adaptive Staircase Algorithm when stepping occurs]; d) Ground reaction forces and moments for each foot.

Methods related to Specific Aim 2 SA-2.1: Evaluate the Assessment Module's test-retest reliability and compare subject performance in it to that in established clinical measures of balance, reach, and Fear of Falling. Twenty stroke (STR) adults will undergo two tests with the Assessment Module 48 hours apart. Clinical measures will be administered before each test. Test-retest reliability will be evaluated

SA-2.2: Evaluate the Training Module's motor learning effect of three one-hour training sessions over one week. Ten subjects randomly selected from those that participated in SA-2.1 will undergo three one-hour training sessions for one week. The SA-2.1 test-retest data will also serve here as double baseline data to establish before-training balance performance. Subjects will be evaluated using the clinical measures at the beginning and immediately after training. Motor learning will be assessed using data from the baseline assessments, the clinical measures, and from the Training Module taken from the last 90 sec of the last training bout of each training session.

Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description:
Once the BATP is developed 20 stroke subjects will be recruited and the BATP's Assessment Module will be administered in order to verify its operation. After this is complete 10 stroke subjects will be randomly selected from this group and will undergo three one-hour training sessions over the course of one week to assess the operation of the BATP's Training Module.
Masking: None (Open Label)
Primary Purpose: Other
Condition  ICMJE
  • Balance Deficits
  • Stroke
Intervention  ICMJE Diagnostic Test: Balanced Reach Assessment and Training Protocol
Three one-hour training sessions for one week in the Balanced Reach Training Protocol
Study Arms  ICMJE STR
Older people who have suffered a stroke
Intervention: Diagnostic Test: Balanced Reach Assessment and Training Protocol
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Not yet recruiting
Estimated Enrollment  ICMJE
 (submitted: June 20, 2019)
20
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE June 30, 2022
Estimated Primary Completion Date June 30, 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Ischemic stroke with residual hemiparetic gait
  • Adequate language and neurocognitive function to participate in testing and training
  • Able to give adequate informed consent
  • Completion of all regular physical therapy
  • Capable of performing the BATP Assessment and Training tasks without assistive devices or handholds
  • Able to tolerate the use of AVR eyewear for ~10 minutes

Exclusion Criteria:

Clinical history of:

  • unstable angina
  • recent myocardial infarction (< 3 month) or hemodynamically significant congestive heart failure (NYHA II) or valvular dysfunction
  • peripheral arterial occlusive disease with claudication
  • major orthopedic, chronic pain, or conditions restricting exercise
  • pulmonary or renal failure
  • Body Mass Index (BMI) >40
  • active vertigo
  • symptomatic orthostatic hypotension
  • poorly controlled hypertension (>190/105) on at least two separate occasions
  • poorly controlled type 1 or 2 diabetes (HbA1c >10)
  • recent hospitalization for severe disease or surgery (<3 month)
  • excessive daily alcohol consumption (>3 oz. liquor; >12 oz. wine; or >36 oz. beer) or illicit drug abuse
  • untreated major clinical depression or dementia
  • major neurological disease other than stroke, such as Parkinson's disease, multiple sclerosis, etc.
  • any condition (e.g., extreme obesity or frailty) that would preclude safe completion of the BATP
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 65 Years to 86 Years   (Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Joseph E Barton, MD PhD (202) 337-5921 jbarton@som.umaryland.edu
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03994770
Other Study ID Numbers  ICMJE A3020-P
I21RX003020 ( U.S. NIH Grant/Contract )
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party VA Office of Research and Development
Study Sponsor  ICMJE VA Office of Research and Development
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Joseph E. Barton, MD PhD Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
PRS Account VA Office of Research and Development
Verification Date June 2021

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP